Yutaka Kurebayashi

Assistant Professor

Keio University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yutaka Kurebayashi is an Assistant Professor at Keio University School of Medicine in Japan. His research encompasses various areas, including the immunovascular characteristics of hepatocellular carcinoma, the dynamics of T- and B-cell responses, and the transcription factor landscape of neuroendocrine tumors. His recent publications focus on tumor heterogeneity, immuno-vascular classifications, and therapeutic implications in advanced hepatocellular carcinoma.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Associate Professor

Keio University

JAPAN

View details

Ryuhei Okada

Specially Appointed Assistant Professor

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yutaka Kurebayashi

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Vessels encapsulating tumor clusters contribute to the intratumor heterogeneity of HCC on Gd-EOB-DTPA–enhanced MRI

Lineage-specific transcription factor landscape of thymic neuroendocrine tumors

Intracellular Protein Binding of Zr-89 Oxine Cell Labeling for PET Cell Tracking Studies

Macrotrabecular hepatocellular carcinoma: Unique immunovascular characteristics

Spatial Dynamics of T- and B-Cell Responses Predicts Clinical Outcome of Resectable and Unresectable Hepatocellular Carcinoma

Comparative Immunohistochemical Analysis of Clinicopathological Subgroups in Hepatocellular Carcinomas from Japan and Indonesia

Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy

Immunovascular microenvironment in relation to prognostic heterogeneity of WNT/β‐catenin‐activated hepatocellular carcinoma

TNFRSF13B c.226G>A (p.Gly76Ser) as a Novel Causative Mutation for Pulmonary Arterial Hypertension

Immuno‐vascular Classification of HCC Reflects Reciprocal Interaction between Immune and Angiogenic Tumor Microenvironments

Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

Lipofibroadenoma arising in hyperplastic thymic tissue: Possible perivascular origin of lipofibroadenoma

Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications

Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin

IL-6 and G-CSF production resulting from lung cancer in an HIV patient

Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma

Collaborators (8)

Shinichi Goto

Jin Endo

Akihisa Ueno

Hanako Tsujikawa

Rui Nomura

Motoaki Sano

Yuta Abe

Ryuhei Okada

Make your next move.